Iovance Grants Stock Options Covering 111,615 Shares to 21 New Employees

Iovance Biotherapeutics granted inducement stock options covering 111,615 shares to 21 new, non-executive employees on October 15, 2026. The awards fall under the Amended and Restated 2021 Inducement Plan. Options vest over three years, with one-third vesting on the first anniversary of each employee’s start date. Remaining shares vest in eight quarterly installments over the following two years, subject to continued employment through each vesting date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via (Ref. ID: 202610161715PRIMZONEFULLFEED9847665) on October 16, 2026, and is solely responsible for the information contained therein. (C)